The Centers for Medicare & Medicaid Services is conducting through Sept. 30 a second review and corrections period for the fiscal year 2017 Hospital Acquired Condition Reduction Program due to an error in calculating Clostridium difficile infection performance during the first two quarters of 2014. CMS also has updated the baseline period performance standard for the FY 2018 value-based purchasing program, and intends to update the archived databases of Hospital Compare to reflect corrected performance data. For more information, see CMS’s QualityNet website.

Related News Articles

Headline
A new issue brief from AHA’s Hospitals Against Violence initiative offers proven strategies and action steps to help hospitals and health systems’ violence…
Headline
AHA urged leaders of the Senate and House Appropriations Subcommittees on Labor, Health and Human Services, and Education to give favorable funding…
Headline
The Department of Justice May 9 announced the formation of a task force focusing on competition concerns in health care. The unit, the Task Force on Health…
Headline
The Food and Drug Administration April 29 issued a final rule that would phase out its general enforcement discretion approach for most laboratory developed…
Headline
Pediatric sepsis is "an aggressive and unrelenting adversary that knows neither geographic nor demographic bounds," writes Chris DeRienzo, M.D., AHA’s senior…
Headline
The Centers for Disease Control and Prevention and Food and Drug Administration are investigating adverse effects in 22 people in 11 states who received…